Faruqi & Faruqi investigating Picard Medical securities class action, deadline to seek lead plaintiff is April 13, 2026.

AI Summary2 min read

TL;DR

Faruqi & Faruqi is investigating a securities class action against Picard Medical for alleged false statements and stock manipulation from September 2 to October 31, 2025, with a lead plaintiff deadline of April 13, 2026.

Tags

securities class actionPicard MedicalFaruqi & Faruqistock fraudinvestor claims

• Faruqi & Faruqi investigating claims against Picard Medical. • Deadline to seek lead plaintiff is April 13, 2026. • Securities class action filed against the company. • Potential claims for investors who suffered losses between September 2, 2025 and October 31, 2025. • Contact Faruqi & Faruqi partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) for options.

Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against Picard Medical, Inc. (NYSE: PMI) related to a federal securities class action. The firm alleges that the company and its executives may have violated federal securities laws by making false or misleading statements or failing to disclose material information between September 2, 2025, and October 31, 2025. Specifically, the claims center on allegations that Picard was involved in a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals, as well as coordinated share dumping via offshore or nominee accounts during a price inflation campaign. Additionally, the complaint states that Picard's public disclosures omitted critical details about false rumors and artificial trading activity affecting its stock price.

On October 24, 2025, PMI shares plummeted by 59.8%, closing at $5.31 after trading at $13.20 the previous session, marking one of the steepest single-day declines since the company's IPO. Investors who purchased securities during the specified period may be eligible to seek remedies through the class action. The deadline to seek appointment as lead plaintiff in the case is April 13, 2026.

Investors wishing to discuss their legal options are encouraged to contact Faruqi & Faruqi partner James (Josh) Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) according to the firm. The firm also invites individuals with relevant information about Picard's conduct to reach out confidentially.

This notice is part of ongoing legal proceedings, and the outcomes of such cases are not guaranteed.

Faruqi & Faruqi investigating Picard Medical securities class action, deadline to seek lead plaintiff is April 13, 2026.

Visit Website